SPOTLIGHT -
Willpower and ADHD
Experts discuss the role of motivation and willpower in ADHD at the 2022 APA Annual Meeting.
Neurological and Neuropsychiatric Complications of COVID-19
An expert discusses the effects of long COVID on the brain at the 2022 APA Annual Meeting.
Cults in the Age of Influence
Experts discuss appropriate interventions for patients who are victims of undue influence at the 2022 APA Annual Meeting.
Leading the Artificial Intelligence Revolution
Experts discuss psychiatry’s role in the advancement of AI technologies at the 2022 APA Annual Meeting.
Assessing Gaps and Opportunities in ECT, rTMS, and DBS Guidelines
The 2022 APA Annual Meeting highlights the latest guidelines for these treatments, plus recommendations for updates and improvements.
Clearing the ‘Brain Fog’ in Long COVID
Experts address cognitive dysfunction found in patients with long COVID at the 2022 APA Annual Meeting.
Understanding the Neurobiology of PTSD
How can we more effectively help patients with PTSD? Charles B. Nemeroff discusses the diagnosis, epidemiology, and pathophysiology of PTSD, along with current and emerging treatments, at the 2022 APA Annual Meeting.
Major Diagnostic Differences Between DSM-5 and ICD-11
Do classification systems make a difference? A presentation at the 2022 APA Annual Meeting noted 4 key diagnoses that differ significantly in the classification systems.
Chester M. Pierce Human Rights Award Winner to Give Inaugural Award Lecture at 2022 APA Annual Meeting
This year’s winner is a pioneer for the human rights of individuals with mental illness in West Africa.
Study Examines Relationship Between Methylphenidate and Risk of Depression
Investigators observed higher levels of depression in children and adolescents with ADHD during MPH treatment.
Study Examines Best Practices for Managing Perinatal Depression
Recommendations are often vague, contradictory, according to investigators.
Study Explores Link Between ADHD and Internet Gaming Disorder
Some of the more severe ADHD symptoms noted were depression/withdrawal, problems with socialization.
Phase 3 Study on Treatment of Agitation in Alzheimer Disease Doses First Patient
Top-line data for study is expected in late 2022, early 2023.
Study Shows 2 in 5 Adults with ADHD are in Exceptional Mental Health
Physical activity, marital status among factors contributing to complete mental health among participants.
FDA Approves Novel Nonstimulant for Treatment of ADHD in Adults
Approval comes 1 year after the drug was approved for the treatment of ADHD in children and adolescents.
Support Gathers for Biden Administration’s 2022 National Drug Control Strategy
Strategy highlights plans of action to address untreated addiction, overdose epidemic.
Individuals Cite Exercise, Gaming as Top Ways to Address Mental Health Issues
The most common issues during the COVID-19 pandemic included stress, anxiety.
APhA Conference Addresses Depression, Benzos
Catch up on all the latest from the American Pharmacists Association (APhA) Annual Meeting & Exposition.
FDA Sends Warning to Websites Over Illegal Sale of Adderall
The warnings cite consumer risks, as well as FD&C, RHA violations.
Study Identifies Urgent Need for More Research on Pain in Severe Mental Illness
Evidence review focuses on bipolar disorder, psychosis, and major depression.
In Case You Missed It: Medical World News Season 5
In Season 5, the psychiatric community weighed in on everything from finding meaning in music to the importance of mindfulness.
Research Explores Neurocognitive Profile, Cognitive Impairment in MDD
Study supports evidence for long-term impairment in memory, executive function.
Celebrating Women Who Inspire
In honor of Women's History Month, our contributors celebrate the women who inspire them.
Study Assesses Current Research on Blue Light Blocking Treatment for Bipolar Disorder
Although research is limited, the results are promising.
Study Links Lithium With Lower Risk of Dementia
Research also finds surprising results in patients with bipolar affective disorder.
Research Roundup: Psychiatric Comorbidities in the News
Catch up on all the latest in psychiatric comorbidities.
Study Shows Risk Awareness of Concurrent Benzodiazepine, Opioid Use Among Patients
Results highlight the impact of education on patient understanding of potential adverse events.
Seeing Things: Mind or Brain?
Researchers explore the psychiatric and neurological etiologies of visual hallucinations.
Study Shows Effects of Antidepressant Use on Lipid Biomarkers
Results are clinically significant for the treatment of patients with major depressive disorder.
Research Identifies Key Differences Between LSD and Psilocybin
Drug comparison has significant implications for dose- and substance-dependence.